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Ionising radiation is commonly used in the treatment of colorectal cancer. Tumour cells with mutant p53 undergo cell cycle
arrest at G2/M after ionising radiation and evidence suggests that abrogation of this G2 arrest can lead to a premature,
aberrant mitosis, thus enhancing ionising radiation-induced cell killing. The G2 checkpoint inhibitor UCN-01 was thus
investigated to determine whether it would abrogate the G2 checkpoint induced by 5 Gy ionising radiation in a range of
colorectal tumour cell lines. Data presented show that, at doses that are alone non-toxic to the cells, UCN-01 inhibits the
ionising radiation-induced G2 checkpoint in ﬁve colorectal tumour cell lines with mutant p53. The ability of UCN-01 to
sensitise cells to ionising radiation-induced growth inhibition and apoptosis was also investigated and UCN-01 was found to
radiosensitise two out of ﬁve cell lines. These results were conﬁrmed by long-term colony forming efﬁciency studies. These
results demonstrate that abrogation of the ionising radiation-induced G2 checkpoint is not necessarily associated with
sensitisation to ionising radiation, however, some colorectal tumour cell lines can be radiosensitised by UCN-01. Although the
mechanism of radiosensitisation is not clear, this may still be an important treatment strategy.
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Mutations in the p53 tumour suppressor gene have been observed
in many epithelial tumours and leukaemias (Hollstein et al, 1991),
including approximately 80% of colorectal carcinomas (Vogelstein
et al, 1988), and this can be associated with resistance to IR-
induced cell death in some cell types (Lee and Bernstein, 1993;
Nagasawa et al, 1994; Siles et al, 1996). After DNA damage, for
example by ionising radiation (IR), cells undergo arrest at the
G1 and G2 phases of the cell cycle. The G1 arrest is dependent
on wild type p53 function (Kastan et al, 1991; Kuerbitz et al,
1992), whereas the G2 arrest can occur in the absence of wild type
p53 (Kastan et al, 1991; Bracey et al, 1995), however p53 may play
a role in the G2 arrest in some cell types (Agarwal et al, 1995;
Hermeking et al, 1997). Cell cycle checkpoints are believed to allow
time for DNA repair and therefore, in tumour cells with mutated
p53, the G2 checkpoint is the last remaining point at which DNA
damage can be repaired prior to mitosis and cell division (reviewed
in Weinert, 1998).
Abrogation of the G2 checkpoint has been associated with sensi-
tisation of tumour cells to DNA damaging agents. For example,
agents such as the methylxanthines caffeine and pentoxifylline have
been shown to abrogate the G2 checkpoint and increase sensitivity
to IR, presumably due to the ability of these agents to cause
premature, and hence lethal, mitosis after IR (Powell et al, 1995;
Bracey et al, 1997). Abrogation of the G2 checkpoint and subse-
quent sensitisation to DNA damage-induced cell death is
suggested to be speciﬁc to cells that do not express wild type
p53, as these cells depend on the G2 arrest for survival after
DNA damage (Powell et al, 1995; Bunch and Eastman, 1996; Wang
et al, 1996; Bracey et al, 1997). Hence this may be an important
treatment strategy as tumour cells may be preferentially targeted
whilst causing minimal disruption to surrounding non malignant
tissue. It has previously been demonstrated that colorectal tumour
cell lines are radiosensitised by caffeine in a mutant p53-speciﬁc
manner (Bracey et al, 1997), however caffeine is inappropriate
for use in humans as doses required to achieve this effect show
central nervous system and cardiac toxicities.
7-hydroxystaurosporine (UCN-01) was originally isolated from a
Streptomyces species as an inhibitor of protein kinase C (PKC)
(Akinaga et al, 1991; Mizuno et al, 1993). UCN-01 has anti-tumour
properties alone (Akinaga et al, 1991; Seynaeve et al, 1994) and has
also been shown to abrogate the G2 checkpoint and to sensitise
tumour cells to various DNA damaging agents (Bunch and East-
man, 1996; Wang et al, 1996; Yu et al, 1998). In view of these
properties, UCN-01 has recently undergone phase I clinical trials
(Senderowicz and Sausville, 2000). Potential targets of UCN-01
are currently under much investigation and it is suggested to act
speciﬁcally at the G2/M transition. Cell cycle arrest at G2 is tightly
controlled by a series of phosphorylation reactions (reviewed in
Hwang and Muschel, 1998; Russell, 1998). In short, IR induces a
G2 arrest through inactivation of the cyclin B/Cdc2 complex.
Cyclin B/Cdc2 is retained in an inactive state by phosphorylation
at threonine 14 and tyrosine 15, and dephosphorylation of these
residues by Cdc25C is critical for activation and progression to
mitosis (reviewed in Zhou and Elledge, 2000). UCN-01 has been
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Cdc25C, and UCN-01 is proposed to cause premature entry into
mitosis in this way (Busby et al, 2000; Graves et al, 2000).
Colorectal cancer is the second most common cause of cancer
death in the Western world and hence improvement of existing
treatments will signiﬁcantly reduce the morbidity and mortality
associated with this disease. Previous work by Wang et al (1996)
has shown that UCN-01 sensitises the colorectal carcinoma cell line
HT29 to IR-induced growth inhibition, however, it is not known
whether this is a general response of all colorectal tumour cells.
Given the frequent use of radiotherapy in treatment of colorectal
cancer and the potential importance of this therapeutic strategy,
the aim of this study was to determine whether UCN-01 was able
to abrogate the IR-induced G2 arrest in a range of colorectal
tumour cell lines, and whether this would consistently lead to
radiosensitisation in these cell lines.
MATERIALS AND METHODS
Cell lines and culture conditions
HT29 is derived from a human sporadic colon carcinoma (Fogh
and Trempe, 1975) and has mutant p53 (Rodrigues et al, 1990).
SW480 is derived from a human rectal carcinoma (Leibovitz et
al, 1976) and has mutant p53; SW620 was derived from a lymph
node when this cancer recurred with widespread metastasis (Leibo-
vitz et al, 1976). S/KS is derived from a human sporadic rectal
carcinoma (Hague et al, 1993) and expresses high levels of trun-
cated p53 (Williams et al, 1993). The S/RG/C2 cell line is
derived from a human sporadic colorectal adenoma and is hemizy-
gous at the p53 locus, and the remaining allele is mutated (Baker et
al, 1990).
The carcinoma (HT29, SW480, SW620 and S/KS) and adenoma
(S/RG/C2) cell lines were maintained in Dulbecco’s Modiﬁed
Eagle’s Medium (DMEM) supplemented as described previously
(Bracey et al, 1995, 1997). All cell lines were grown in 25 cm
2
(T25) tissue culture ﬂasks and maintained at 378Ci n5 %C O 2
LEEC dry incubators.
Treatment with 5 Gy IR+UCN-01
Cells were seeded in duplicate ﬂasks in standard growth medium
at a density of either 1610
6 (carcinomas) or 2610
6 (adenoma
S/RG/C2). Cells in the exponential phase of growth were exposed
to 5 Gy g IR using a
137Cs generator (Gravatom) at a dose rate
of 0.33 Gy per min (as described previously, Bracey et al, 1995).
Control cultures were mock irradiated. Immediately after IR cells
were treated with normal growth medium containing either 25,
50 or 300 nM UCN-01 (Drug Synthesis and Chemistry Branch,
Developmental Therapeutics program, Division of Cancer Treat-
ment, National Cancer Institute) which was prepared as a
10 mM stock solution in DMSO. Cells were grown for 7 days
and the medium was replaced with fresh medium containing
UCN-01 every 3–4 days, or with fresh medium after 24 h,
depending on experiment.
Assessment of cell cycle distribution
Cell cycle arrest after IR was determined using a FACScan
(Becton Dickinson), as described previously (O’Connor et al,
1993; Bracey et al, 1995). Either 12, 18 or 24 h after IR, dupli-
cate ﬂasks of cells were trypsinised and cells were stained with
propidium iodide prior to analysis on a FACScan using Cell-
Quest software (distributed by Becton Dickinson). Cell cycle
distribution was determined using either Modﬁt (Verity Software
House, ME, USA) or WinMDI (Joseph Trotter, Scripps Institute)
software.
Mitotic index
The percentage of mitotic cells after IR and/or UCN-01 was deter-
mined to conﬁrm that cells underwent a ‘true’ G2 cell cycle arrest
that was completely abrogated. Cells were seeded onto glass slides
at a density of 0.5610
6 cells per slide. After 3 days, slides were
irradiated with 5 Gy and/or UCN-01 or mock irradiated. At
various times after IR cells were ﬁxed and stained with the DNA
dye Hoechst 33258 (0.5 mgm l
71; Sigma). Mitotic cells were scored
for the characteristics of mitosis, that is visible, evenly stained
chromosomes as described previously (Bunz et al, 1998), and at
least 400 cells were scored for each sample.
Treatment with colcemid
The mitotic inhibitor colcemid (Gibco) was added to exponentially
growing cells (grown on slides as described above) immediately
after IR and/or UCN-01 treatment at a dose of 0.01–0.04 mgm l
71
depending on cell line. Preliminary experiments were carried out to
determine the appropriate concentration of colcemid (HT29,
0.04 mgm l
71; SW620, 0.01 mgm l
71; S/RG/C2, 0.02 mgm l
71). At
speciﬁc timepoints after treatment mitotic index was determined
as described above.
Determination of attached cell yield
Attached cell yield was calculated in order to determine cell survi-
val after treatment with IR and/or UCN-01. Duplicate ﬂasks were
trypsinised and attached cells were quantiﬁed using a counting
chamber.
Measurement of apoptosis
We have previously shown that 5 Gy IR can induce apoptosis in
colorectal adenoma and carcinoma cell lines (Bracey et al, 1995,
1997). Cells that are detached from the monolayer and ﬂoat into
the culture medium show both morphological and biochemical
features of apoptosis and the majority of cells that remain attached
do not show features of apoptosis (Hague et al, 1993; Bracey et al,
1995; Shureiqi et al, 2000). The medium was removed from the
ﬂasks every 3-4 days and numbers of cells with characteristics of
apoptosis were counted. Apoptosis was conﬁrmed by acridine
orange staining (as described previously, Hague et al, 1993, Bracey
et al, 1995); ﬂoating cells were stained with 5g/ml acridine orange,
and analysed by ﬂuorescent microscopy for morphological features
of apoptosis, most obviously condensed chromatin (as described in
Hague et al, 1993). At least 200 cells were scored for each treat-
ment. The proportion of ﬂoating cells that were apoptotic did
not signiﬁcantly vary between treated and untreated cells and
therefore the number of ﬂoating cells was used to indicate % apop-
tosis, which was calculated as number of ﬂoating cells as a % of the
total cell number. (described previously, Hague et al, 1993; Bracey
et al, 1995).
The attached cell population was also analysed for the presence
of apoptotic cells by acridine orange staining; in all cell cultures
less than 1% of the attached population showed morphological
features of apoptosis. The attached population was also examined
for the formation of giant, polyploid cells. These are cells that
are proposed to arise from checkpoint disruption and the comple-
tion of multiple rounds of DNA synthesis without mitosis
(Waldman et al, 1996), leading to cell death. Attached cells were
stained with acridine orange and cells of greater than 30 mm
diameter were scored as giant, using an eye piece graticule. In this
investigation control cells were less than 25 mm diameter
(described previously, Bracey et al, 1997). In all cell cultures there
was no evidence of an increase in giant cells in the attached popu-
lation.
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After 7 days of treatment with IR and/or UCN-01 attached cell
yield was determined (as described above) and 1610
3 cells from
each treatment were then re-seeded in T25 ﬂasks with fresh
(untreated) medium. The ﬂasks were incubated for a further 14
days and medium was replaced every 3–4 days during this time.
The attached cells were then ﬁxed in 10% formaldehyde (in PBS;
BDH) overnight and then stained with methylene blue (Sigma)
overnight. The methylene blue dye was then washed off with water
and colonies of greater than 50 cells were counted and colony
forming efﬁciency (CFE) was calculated as a proportion of the
original cell number seeded.
Statistical analysis
A two-tailed, paired, students t-test was performed on combined
treatments of IR and UCN-01, to determine whether there was a
signiﬁcant difference between treatment with a combination of
UCN-01 and IR, compared to IR alone. A P value of 50.05 was
taken as signiﬁcant and *=P50.05, **=P50.01, ***=P50.001.
RESULTS
UCN-01 abrogates the G2 arrest induced by 5 Gy IR
Colorectal tumour cell lines with mutant p53 treated with 5 Gy IR
arrest at the G2 phase of the cell cycle and this is maximal 12 to
24 h after IR, depending on cell line (Bracey et al, 1995). To deter-
mine the effect of UCN-01 on the G2 cell cycle checkpoint, four
colorectal carcinoma-derived cell lines and one colorectal adeno-
ma-derived cell line were irradiated with 5 Gy and then
incubated in medium containing UCN-01 for 12–24 h, depending
on cell line, and then prepared for analysis by FACS.
Preliminary studies were carried out to determine a dose of
UCN-01 that alone was non-toxic to the cell lines over a 7 day
period. As shown in Table 1, treatment with non-toxic doses of
UCN-01 (25–50 nM) alone had very little effect on cell cycle distri-
bution. The colorectal carcinoma cell lines HT29, SW480, SW620,
S/KS and the adenoma cell line S/RG/C2 all undergo a delay at the
G2 phase of the cell cycle after 5 Gy IR.
Treatment with IR and UCN-01 resulted in a clear abrogation of
the G2 arrest (Table 1). In all ﬁve cell lines, IR causes an accumu-
lation of cells in the G2 phase of the cell cycle and addition of
UCN-01 results in a reduction of cells in G2, similar to control
untreated levels. In all cell lines the cell cycle arrest at G2/M was
conﬁrmed to be a true G2 arrest by determination of the mitotic
index (as described in Materials and Methods). For example, in
the HT29 cell line, the percentage of mitotic cells in unirradiated
cultures remained constant (5.3+1.13%). In the cultures treated
with 5 Gy IR, mitotic frequency was decreased to 51% 12 h after
IR and remained low (52%) at 24 h post IR. By 48 h post IR the
mitotic frequency was similar in treated and control cell cultures
(see also Table 2 for S/RG/C2 and SW620 data). To conﬁrm that
UCN-01 was having an effect at the G2 checkpoint and not prior
to the checkpoint, experiments were carried out using colcemid
which is known to inhibit spindle formation and therefore blocks
M phase. As expected colcemid treatment alone resulted in an
increase in the number of cells in mitosis in HT29, SW620 and
S/RG/C2 (Table 2). IR and UCN-01 combined treatment had little
effect on the mitotic index consistent with UCN-01 inhibiting the
IR induced G2 arrest. Furthermore, IR and UCN-01 in the
presence of colcemid resulted in a large increase in the mitotic
index in all three cell lines (Table 2) showing that the cells are
indeed progressing through G2 then being inhibited in M phase
by the colcemid. These data are consistent with UCN-01 having
its effect at the G2 checkpoint and thus resulting in IR and
UCN-01-treated cells progressing through M phase.
Radiosensitisation by UCN-01 is seen in two colorectal
carcinoma cell lines
We next examined whether the combined treatment of IR and
UCN-01 results in a decrease in cell yield (compared to either
treatment alone) and/or an increase in the proportion of apoptotic
cells (compared to either treatment alone). Apoptosis was exam-
ined in the ﬂoating and attached cell populations.
Attached cell yield was used as a determinant of cell survival 7 days
after IR. In all cell lines investigated 5 Gy IR caused a reduction in cell
yield (for example, Figures 1a,c and 2a). Addition of UCN-01 after IR
resulted in a further signiﬁcant reduction in cell yield compared to IR
alone in the HT29 and SW480 cell lines (P50.05, Figure 1a,c). In the
S/RG/C2, SW620 and S/KS cell lines addition of UCN-01 did not
result in any additional reduction in cell yield when compared to
IR alone (for example S/RG/C2, Figure 2a).
It was also important to determine whether the observed
reduction in cell yield was due to an increase in apoptosis. As
described previously, the level of apoptosis in cultured epithelial
cell lines can be assessed by measuring the proportion of cells that
have detached from the monolayer and are ﬂoating in the
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Table 1 UCN-01 abrogates the IR-induced G2 checkpoint in colorectal tumour cell lines
Untreated UCN-01 IR IR+UCN-01 combined
Cell line G1 S G2/M G1 S G2/M G1 S G2/M G1 S G2/M
HT29 48.43 43.71 7.87 58.49 34.48 7.03 47.45 26.63 25.92 56.43 31.97 11.60
(+3.56) (+5.67) (+2.11) (+3.04) (+4.60) (+1.57) (+6.14) (+2.09) (+4.27) (+2.72) (+2.10) (+0.96)
SW480 51.16 35.46 13.39 54.27 32.33 13.41 19.36 40.83 39.81 47.63 33.64 18.72
(+3.34) (+2.65) (+0.96) (+4.87) (+1.21) (+4.15) (+6.97) (+8.78) (+10.31) (+7.37) (+2.60) (+4.96)
SW260 54.17 34.64 11.17 64.46 25.61 9.92 23.12 20.23 56.65 65.10 20.52 14.38
(+3.54) (+3.67) (+0.68) (+3.92) (+3.06) (+1.46) (+4.18) (+7.41) (+11.55) (+12.74) (+6.59) (+6.18)
S/KS 50.02 38.30 11.67 59.74 30.67 9.59 19.77 39.34 40.89 54.04 27.49 18.46
(+5.78) (+5.55) (+0.92) (+3.25) (+1.31) (+1.94) (+.4.34) (+7.96) (+4.43) (+12.77) (+7.43) (+5.77)
S/RG/C2 65.31 28.04 6.65 68.13 25.77 6.11 44.33 25.85 29.81 61.34 28.16 10.50
(+9.98) (+10.50) (+1.34) (+10.53) (+11.08) (+2.15) (+10.68) (+11.40) (+0.76) (+4.62) (+4.80) (+3.97)
Colorectal carcinoma cell lines HT29, SW480 and SW620 were treated with 50 nM UCN-01 and adenoma S/RG/C2 and carcinomas S/KS were treated with 25 nM UCN-01
immediately after irradiation with 5 Gy. These doses of UCN-01 were the maximum dose that was alone non-toxic to the cells. At the time of maximum G2 arrest after IR (12
to 24 h after IR, depending on cell line) duplicate ﬂasks were trypsinized and prepared for analysis by ﬂow cytometry as described in Materials and Methods. In all cell lines,
treatment with UCN-01 alone had a small effect on cell cycle distribution compared to untreated control cells. Five Gy IR caused an increase in the proportion of cells in
G2/M. In all cell lines treatment with IR and UCN-01 resulted in a clear abrogation of the G2 arrest. Each data point represents mean percentage of cells in G1, S or G2/M
from three independent experiments+s.d.
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then examined for morphological features of apoptosis, most
obviously condensed chromatin. In both HT29 and SW480 cell
lines the reduction in cell yield seen in cells treated with a combi-
nation of IR and UCN-01 compared to IR alone was associated
with a signiﬁcant increase in the proportion of ﬂoating cells that
were found to be apoptotic (P50.05 and P50.01, Figure 1b,d).
There was no evidence of an increase in apoptosis in S/RG/C2,
SW620 and S/KS in cultures treated with a combination of IR
and UCN-01 compared to IR alone (for example S/RG/C2, Figure
2b).
Although an increase in apoptosis is usually detected by an
increase in the proportion of ﬂoating cells, it is possible that the
attached cells may show features of apoptosis. Therefore, in all
cases the attached cell populations were also examined for charac-
teristics of apoptosis. However, there was no increase in apoptosis
in attached cells (for example in S/RG/C2 the level of apoptosis in
the attached cell population was consistently less than 1% in
control and treated cultures). These cells were also investigated
for the presence of giant polyploid cells. These are cells which
are proposed to have undergone multiple rounds of DNA synthesis
in the absence of mitosis which may result from checkpoint
disruption (Waldman et al, 1996). We have previously shown that
in colorectal cell lines the G2 checkpoint after IR can be abrogated
by 1.5 mM caffeine and that in some cell lines radiosensitisation is
not associated with an increase in apoptosis but with an increase in
giant cells in the attached population (Bracey et al, 1997). We
examined those cells lines in which checkpoint abrogation was
not associated with radiosensitisation, as assessed by increase in
apoptosis, for the presence of giant cells in the attached popula-
tion. There was no increase in giant cells in those cultures
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Figure 1 Radiosensitisation of carcinomas HT29 and SW480 by UCN-01. Survival of the HT29 (A) and SW480 (C) carcinoma cell lines, which have
mutant p53, was assessed by attached cell yield after 7 days treatment with 5 Gy IR and/or 50 nM UCN-01. Treatment with UCN-01 alone had no effect on
the attached cell yield compared to untreated control cells. IR alone reduced cell yield and this was further signiﬁcantly reduced by combined treatment with
IR and UCN-01. Data represents means of three independent experiments+s.d.; *Signiﬁcant reduction in cell yield in IR and UCN-01 (combined) cultures
compared to IR alone, P50.05. Induction of apoptosis of the HT29 (B) and SW480 (D) carcinoma cell lines was assessed by determining the percentage of
cells which had detached from the monolayer and were ﬂoating, these cells were then determined to be apoptotic as described previously (Bracey et al,
1995), also see Materials and Methods. Treatment with UCN-01 alone had no effect on levels of apoptosis. After treatment with both 5 Gy IR and 50 nM
UCN-01 (combined) there was a signiﬁcant increase in apoptosis compared to IR alone. Data represents means of three independent experiments+s.d.;
*Signiﬁcant increase in ﬂoating cells in IR and UCN-01 (combined) cells compared to IR alone, *=P50.05, **=P50.01.
Table 2 Colcemid increases the number of mitotic cells in IR and UCN-
01 treated cells
HT29 SW620 S/RG/C2
Untreated control 5.28+1.13 5.38+2.3 4.83+2.7
IR 0.49+0.28 2.57+0.9 0.84+0.7
UCN-01 4.81+2.6 3.79+1.6 3.95+1.9
Colcemid 32.02+13.1 14.76+11.7 24.73+7.9
UCN-01+Colcemid 22.23+4.2 23.61+10.5 20.10+7.2
IR+UCN-01 6.32+2.7 6.00+3.6 3.47+1.2
IR+UCN-01+Colcemid 39.83+10.7 18.70+6.2 23.78+10.4
Colorectal HT29, SW620 and S/RG/C2 cells were grown on slides and when in the
exponential phase of growth were treated with 5 Gy IR and/or UCN-01 and/or
colcemid. At the time of maximum G2 slides were ﬁxed and stained with Hoechst
33258 and scored for the number of cells in mitosis as a percentage of the total cell
number. Each data point represents the mean percentage of mitotic cells from two
independent experiments+s.d.
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(data not shown).
A higher dose of UCN-01 does not radiosensitise S/RG/C2
Data shown above demonstrate that the HT29 and SW480 cell lines
were radiosensitised by treatment with 50 nM UCN-01 (Table 1 and
Figure 1). Although treatment with 25 nM UCN-01 (a non-toxic
dose in S/RG/C2) abrogated the IR-induced G2 checkpoint in S/
RG/C2 (Table 1), there was no evidence of radiosensitisation in this
cell line (Figure 2). It was of interest, therefore, to determine
whether a higher dose of UCN-01 (300 nM) for a shorter treatment
period (24 h) (a protocol described previously (Wang et al, 1996)),
would be more effective at abrogation of the G2 checkpoint and
would result in sensitisation to IR-induced cell death in the S/RG/
C2 cell line which was not previously sensitised. In both the
HT29 and S/RG/C2 cell lines, treatment with 300 nM UCN-01 effec-
tively abrogated the IR-induced G2 arrest. HT29 was
radiosensitised, similar to that seen with 50 nM treatment for 7 days
as described above (data not shown). However, despite using this
high dose of UCN-01 and following a previously published protocol
(Wang et al, 1996), the S/RG/C2 cell line was still not sensitised to
IR-induced growth inhibition or apoptosis (data not shown).
Long-term colony forming efﬁciency assays conﬁrmed
radiosensitisation
The colorectal cell lines HT29, SW480 and S/RG/C2 were further
investigated to determine whether UCN-01 had any effect on long-
term survival after treatment with 5 Gy IR. After 7 days of treatment
with IR and/or a non-toxic dose of UCN-01, cells were trypsinised
and re-seeded at a known density in control medium without
UCN-01. After a further 14 days of growth, cells were ﬁxed, stained
and CFE was calculated. Results presented in Figure 3a,b show that
the CFE of both the HT29 and SW480 cell lines was not affected by
UCN-01 alone but that CFE was signiﬁcantly reduced in those cells
treated with a combination of IR and UCN-01 compared to IR alone
(P50.05 and P50.001; HT29 and SW480 respectively). Furthermore
the CFE of S/RG/C2 was not signiﬁcantly reduced in those cells trea-
ted with IR and UCN-01 combined, compared to IR alone (P=0.17,
data not shown), thus these long-term studies conﬁrm the observa-
tions of 7 day cell survival.
DISCUSSION
The present study set out to determine whether abrogation of the
IR-induced G2 checkpoint by UCN-01 would lead to sensitisation
of colorectal tumour cells to 5 Gy IR. Previous work has shown
that abrogation of the G2 checkpoint can potentiate cell death
induced by a range of DNA damaging agents (Powell et al, 1995;
Bunch and Eastman, 1996; Wang et al, 1996; Bracey et al, 1997;
Li et al, 1998). Using colorectal adenoma and carcinoma-derived
cell lines Bracey et al (1997) showed that the IR-induced G2 arrest
could be overcome by caffeine, leading to radiosensitisation,
however caffeine has cardiac and central nervous system toxicities
at doses required to inhibit the G2 checkpoint. In the present study
we wished to determine whether radiosensitisation could be
achieved in a range of colorectal adenoma and carcinoma-derived
cell lines (with mutant p53), using UCN-01 at non-toxic doses that
can be tolerated by animals and humans (Hill et al, 1994; Fuse et
al, 1998; Sausville et al, 1998).
Addition of UCN-01 immediately after 5 Gy IR results in an
inhibition of the G2 arrest in all ﬁve cell lines investigated. We
then investigated whether abrogation of the G2 checkpoint after
IR was associated with increased sensitivity to IR. We conﬁrmed
the previous report by Wang et al (1996) that HT29 can be sensi-
tised to IR by UCN-01, interestingly, however, radiosensitisation
was not seen in all cell lines where the G2 arrest was abrogated.
In two carcinoma cell lines (HT29 and SW480), abrogation of
the G2 arrest lead to radiosensitisation as shown by signiﬁcantly
reduced 7 day cell survival in those cells treated with IR and
UCN-01, compared to IR alone. This reduced cell yield was asso-
ciated with a signiﬁcant increase in proportion of cells undergoing
apoptosis, and this data was conﬁrmed by colony forming efﬁ-
ciency studies which showed that long-term survival of HT29
and SW480 treated with IR and UCN-01 was signiﬁcantly reduced,
compared to IR alone.
Unexpectedly in two out of four carcinoma cell lines (SW620
and S/KS) and in the adenoma cell line (S/RG/C2), abrogation
of the G2 arrest after IR did not result in sensitisation to IR. Cell
survival and apoptosis were equal in cells treated with IR and
UCN-01 compared to cells treated with IR alone. This contrasts
with previous data published by our group which has shown that
abrogation of the IR-induced G2 checkpoint by caffeine is asso-
ciated with radiosensitisation in all colorectal cell lines
investigated with mutant p53 (Bracey et al, 1997). Although radio-
sensitisation is usually conﬁrmed by analysis of attached and
ﬂoating (apoptotic) cells, we wished to conﬁrm that there was
not an increase in apoptosis in the attached cell populations. An
increase in morphological features of apoptosis or an increase in
giant polyploid cells in the attached population may have indicated
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Figure 2 UCN-01 did not radiosensitise adenoma S/RG/C2. (A) At-
tached cell yield was determined as a measure of cell survival 7 days after
5 Gy IR and/or treatment with 25 nM UCN-01. Treatment with 25 nM
UCN-01 alone had no effect on attached cell yield compared to untreated
controls. IR alone reduced cell yield and this was not further increased by IR
in combination with UCN-01. Data represents the mean of three indepen-
dent experiments+s.d. (B) Induction of apoptosis was assessed by the
percentage of ﬂoating cells as described previously (Bracey et al, 1995)
and in Materials and Methods. Treatment with UCN-01 alone had no effect
on levels of apoptosis. Five Gy IR induced apoptosis but this was not further
signiﬁcantly increased by IR in the presence of UCN-01. There was no evi-
dence of an increase in apoptosis in the attached population in cells treated
with IR and UCN-01 compared to IR alone, nor was there any evidence of
cell death via formation of giant polyploid cells – see Results.
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of ﬂoating cells. There was no evidence, however, for an increase in
apoptosis or giant cell formation in the attached cell population in
those cultures treated with combined IR and UCN-01 compared to
either treatment alone. The 7 day cell survival and apoptosis data
were also conﬁrmed by colony forming efﬁciency data which indi-
cated that the long-term survival of S/RG/C2 after IR was not
further reduced by the presence of UCN-01.
Thus it appears, at least in colorectal tumour cell lines, that
inhibition of the IR-induced G2 checkpoint is not necessarily asso-
ciated with sensitisation to IR. This in contrast to other reports
which have shown that UCN-01 is able to sensitise tumour cells
to a range of DNA damaging agents, including IR (Akinaga et al,
1993; Bunch and Eastman, 1996; Wang et al, 1996; Shao et al,
1997; Sugiyama et al, 2000). There are other reported cases where
abrogation of the G2 checkpoint is not always associated with
sensitisation to DNA damage-induced apoptosis (Musk, 1991;
Ribeiro et al, 1999) however in these cases the G2 checkpoint
was overcome by caffeine. Caffeine has multiple cellular effects
including inhibition of ATM (Blasina et al, 1999; Zhou et al,
2000) and it is possible that caffeine may radiosensitise cells
through checkpoint-independent mechanisms, such as direct inhi-
bition of DNA repair (Asaad et al, 2000).
The observation in the present study that some colorectal
tumour cell lines cannot be radiosensitised by UCN-01, despite
abrogation of the G2 checkpoint, is intriguing. These data suggest,
ﬁrstly, that lack of both the G1 and G2 arrest in some cell lines
with mutant p53 has a no more detrimental effect on the cells than
lack of a G1 arrest after IR. Secondly, these data suggest that the
G2 checkpoint may be redundant or ineffective in those cells lines
where radiosensitisation was not seen. That is, if the DNA repair
mechanisms were not functional or impaired in the cell lines where
radiosensitisation was not demonstrated, then this would explain
why loss of the G2 checkpoint has no adverse effect on these cells.
In this scenario, the cells would be unable to adequately repair IR-
induced double-strand breaks and therefore would be expected to
undergo apoptosis regardless of the delay at G2. The observation
by Bunch and Eastman (1996) that UCN-01 can abrogate the
cisplatin-induced G2 arrest in CHO cells regardless of DNA repair
status, but that sensitisation to cisplatin is only seen in mismatch
repair-proﬁcient cells suggests that UCN-01 may work through
inhibition of DNA repair pathways (Bunch and Eastman, 1996).
Furthermore Jiang and Yang (1999) propose that UCN-01
suppresses nucleotide excision repair of cisplatin-induced lesions.
In summary, this investigation demonstrates that inhibition of
the IR-induced G2 arrest is not necessarily synonymous with sensi-
tisation to IR. In two out of ﬁve cell lines, however,
radiosensitisation was demonstrated and thus treatment with
UCN-01 may still be an important strategy for colorectal cancer.
To our knowledge this is the ﬁrst report of this nature in a range
of colorectal tumour cell lines and the observation of cell line-
speciﬁc radiosensitisation by UCN-01 may be clinically valuable.
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